Equinix, Inc., a global digital infrastructure firm, has achieved the successful closure of its debut Swiss bond issuance, totaling CHF 300 million 2.875% bonds due in 2028. These bonds were issued through Equinix Europe 1 Financing Corporation and carry
Tags :Stefan Oesterhelt
Homburger acted as counsel to UBS Switzerland as the mandated lead arranger, original lender, and agent for HIAG Group’s recent CHF 500 million sustainability-linked credit facility. With an encompassing business model that spans the entire
Matterhorn Telecom, the parent company of Salt Mobile, issued CHF 100 m 5.250% Senior Secured Notes due 2028 guaranteed by Matterhorn Telecom Holding and Salt Mobile Goldman Sachs International acted as Global Coordinator and Sole Bookrunner.&
Santhera Pharmaceuticals Holding has completed a 10:1 reverse split of its shares, which had been approved by the shareholders on June 27, 2023, with the listing and first day of trading of the post-split shares on the SIX
Homburger has provided legal counsel to Santhera Pharmaceuticals Holding (SIX: SANN “Santhera”) on its completion of a 10:1 reverse split of its shares. The reverse split, which was approved by shareholders on June 27, 2023, resulted in the
Santhera Pharmaceuticals Holding has announced the grant of an exclusive North America license for the commercialization of vamorolone to Catalyst Pharmaceuticals for a total consideration of up to USD 231 million
Bunge has entered into a definitive agreement with Viterra, a private company limited by shares incorporated under the laws of Jersey, together with certain affiliates of Glencore, Canada Pension Plan Investment Board and British Columbia
UBS, acting through its London branch, successfully completed its issuance of (i) CHF 310 million aggregate principal amount of 2.385 per cent. Notes due 2025, and (ii) CHF 150 million aggregate principal amount of 2.550 per cent. Notes due 2029, in
Homburger acted as Swiss counsel to AtlasEdge, a renowned pan-European Edge data centre provider, on a scalable EUR 725 m loan financing. The financing was underwritten by mandated lead arranger ING Bank, as well as ABN
VectivBio Holding, a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare gastrointestinal conditions, and Ironwood Pharmaceuticals, a GI-focused healthcare company, announced that they had entered into an agreement for Ironwood to launch an
